Scientific research shows psychedelic substances like psilocybin hold therapeutic potential for mental health issues, despite legal barriers.
🔗 Read the article on wyborcza.pl
[This is an automatically generated summary, for reference only]
The perception of psychedelic substances in mental health treatment has evolved from being controversial ten years ago to showing significant therapeutic potential based on scientific research. Examples include an EMA-funded study on psilocybin’s role in palliative care. Psilocybin, found in certain mushrooms like those in the Psilocybe genus, affects cognitive processes; scientists clarify that it causes perceptual changes rather than hallucinations. The effects of psilocybin are highly individual, with users often describing transcendental or mystical experiences leading to internal insight and distortion of self/time perception. Proponents argue these experiences can alleviate psychological suffering. Clinical trials suggest psilocybin combined with talk therapy may treat depression, addiction, and existential distress, with therapeutic effects being rapid and long-lasting. A study in “Nature” demonstrated that psilocybin significantly disrupts normal neural communication patterns in the brain, leading to increased brain flexibility and potential for recovery. Psychedelic treatments are not administered regularly but as part of psychedelic-assisted psychotherapy, typically only two or three times, making patients more receptive to therapeutic changes. There is a growing consensus among progressive mental health professionals regarding the medical application of psychedelics. The European Citizens’ Initiative highlights the economic burden of mental illness in the EU (estimated at 4.2% of annual GDP). While some countries like Australia and Canada use these methods, Poland currently classifies psilocybin as a psychotropic substance usable only in scientific research. Researchers at the Medical University of Warsaw are planning studies on psilocybin for treatment-resistant depression, pending ethical approvals. Public awareness regarding psychedelics is increasing, particularly among younger, wealthier urban populations, though many still hold neutral views, suggesting a need for accurate, science-based public education.
